Abstract
A novel tissue-engineered heart valve (TEHV) was fabricated from a decellularized tissue tube mounted on a frame with three struts, which upon back-pressure cause the tube to collapse into three coapting “leaflets.” The tissue was completely biological, fabricated from ovine fibroblasts dispersed within a fibrin gel, compacted into a circumferentially aligned tube on a mandrel, and matured using a bioreactor system that applied cyclic distension. Following decellularization, the resulting tissue possessed tensile mechanical properties, mechanical anisotropy, and collagen content that were comparable to native pulmonary valve leaflets. When mounted on a custom frame and tested within a pulse duplicator system, the tubular TEHV displayed excellent function under both aortic and pulmonary conditions, with minimal regurgitant fractions and transvalvular pressure gradients at peak systole, as well as well as effective orifice areas exceeding those of current commercially available valve replacements. Short-term fatigue testing of one million cycles with pulmonary pressure gradients was conducted without significant change in mechanical properties and no observable macroscopic tissue deterioration. This study presents an attractive potential alternative to current tissue valve replacements due to its avoidance of chemical fixation and utilization of a tissue conducive to recellularization by host cell infiltration.
Similar content being viewed by others
References
Baaijens, F., C. Bouten, S. Hoerstrup, A. Mol, N. Driessen, and R. Boerboom. Functional tissue engineering of the aortic heart valve. Clin. Hemorheol. Microcirc. 33:197–199, 2005.
Christie, G. W. Anatomy of aortic heart valve leaflets: the influence of glutaraldehyde fixation on function. Eur. J. Cardiothorac. Surg. 6:S25–S32, 1992.
Christie, G. W., and B. G. Barratt-Boyes. Mechanical properties of porcine pulmonary valve leaflets: how do they differ from aortic leaflets? Ann. Thorac. Surg. 60:S195–S199, 1995.
Cox, J. L., N. Ad, K. Myers, M. Gharib, and R. C. Quijano. Tubular heart valves: a new tissue prosthesis design–preclinical evaluation of the 3F aortic bioprosthesis. J. Thorac. Cardiovasc. Surg. 130:520–527, 2005.
Dahl, S. L., A. P. Kypson, J. H. Lawson, J. L. Blum, J. T. Strader, Y. Li, R. J. Manson, W. E. Tente, L. DiBernardo, M. T. Hensley, R. Carter, T. P. Williams, H. L. Prichard, M. S. Dey, K. G. Begelman, and L. E. Niklason. Readily available tissue-engineered vascular grafts. Sci. Transl. Med. 3:68ra69, 2011.
Dijkman, P. E., A. Driessen-Mol, L. M. de Heer, J. Kluin, L. A. van Herwerden, B. Odermatt, F. P. Baaijens, and S. P. Hoerstrup. Trans-apical versus surgical implantation of autologous ovine tissue-engineered heart valves. J. Heart Valve Dis. 21:670–678, 2012.
Dijkman, P. E., A. Driessen-Mol, L. Frese, S. P. Hoerstrup, and F. P. Baaijens. Decellularized homologous tissue-engineered heart valves as off-the-shelf alternatives to xeno- and homografts. Biomaterials 33:4545–4554, 2012.
Emmert, M. Y., B. Weber, L. Behr, T. Frauenfelder, C. E. Brokopp, J. Grunenfelder, V. Falk, and S. P. Hoerstrup. Transapical aortic implantation of autologous marrow stromal cell-based tissue-engineered heart valves: first experiences in the systemic circulation. JACC. Cardiovasc. Interv. 4:822–823, 2011.
Flanagan, T. C., C. Cornelissen, S. Koch, B. Tschoeke, J. S. Sachweh, T. Schmitz-Rode, and S. Jockenhoevel. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Biomaterials 28:3388–3397, 2007.
Flanagan, T. C., J. S. Sachweh, J. Frese, H. Schnoring, N. Gronloh, S. Koch, R. H. Tolba, T. Schmitz-Rode, and S. Jockenhoevel. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng. A 15:2965–2976, 2009.
Gerosa, G., V. Tarzia, G. Rizzoli, and T. Bottio. Small aortic annulus: the hydrodynamic performances of 5 commercially available tissue valves. J. Thorac. Cardiovasc. Surg. 131:1058–1064, 2006.
Grassl, E. D., T. R. Oegema, and R. T. Tranquillo. A fibrin-based arterial media equivalent. J. Biomed. Mater. Res. A 66A:550–561, 2003.
Hoerstrup, S. P., R. Sodian, S. Daebritz, J. Wang, E. A. Bacha, D. P. Martin, A. M. Moran, K. J. Guleserian, J. S. Sperling, S. Kaushal, J. P. Vacanti, F. J. Schoen, and J. E. Mayer Jr. Functional living trileaflet heart valves grown in vitro. Circulation 102:III44–III49, 2000.
Isenberg, B. C., and R. T. Tranquillo. Long-term cyclic distention enhances the mechanical properties of collagen-based media-equivalents. Ann. Biomed. Eng. 31:937–949, 2003.
Kim, Y. J., R. L. Sah, J. Y. Doong, and A. J. Grodzinsky. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal. Biochem. 174:168–176, 1988.
Nakayama, Y., Y. Yahata, M. Yamanami, T. Tajikawa, K. Ohba, K. Kanda, and H. Yaku. A completely autologous valved conduit prepared in the open form of trileaflets (type VI biovalve): mold design and valve function in vitro. J. Biomed. Mater. Res. B Appl. Biomater. 99:135–141, 2011.
Neidert, M. R., and R. T. Tranquillo. Tissue-engineered valves with commissural alignment. Tissue Eng. 12:891–903, 2006.
Quint, C., Y. Kondo, R. J. Manson, J. H. Lawson, A. Dardik, and L. E. Niklason. Decellularized tissue-engineered blood vessel as an arterial conduit. Proc. Natl. Acad. Sci. U. S. A. 108:9214–9219, 2011.
Robinson, P. S., S. L. Johnson, M. C. Evans, V. H. Barocas, and R. T. Tranquillo. Functional tissue-engineered valves from cell-remodeled fibrin with commissural alignment of cell-produced collagen. Tissue Eng. A 14:83–95, 2008.
Rouleau, L., D. Tremblay, R. Cartier, R. Mongrain, and R. L. Leask. Regional variations in canine descending aortic tissue mechanical properties change with formalin fixation. Cardiovasc. Pathol. 21:390–397, 2012.
Schmidt, D., P. E. Dijkman, A. Driessen-Mol, R. Stenger, C. Mariani, A. Puolakka, M. Rissanen, T. Deichmann, B. Odermatt, B. Weber, M. Y. Emmert, G. Zund, F. P. Baaijens, and S. P. Hoerstrup. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J. Am. Coll. Cardiol. 56:510–520, 2010.
Shinoka, T., C. K. Breuer, R. E. Tanel, G. Zund, T. Miura, P. X. Ma, R. Langer, J. P. Vacanti, and J. E. Mayer Jr. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann. Thorac. Surg. 60:S513–S516, 1995.
Sodian, R., S. P. Hoerstrup, J. S. Sperling, S. Daebritz, D. P. Martin, A. M. Moran, B. S. Kim, F. J. Schoen, J. P. Vacanti, and J. E. Mayer Jr. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 102:III22–III29, 2000.
Stegemann, H., and K. Stalder. Determination of hydroxyproline. Clin. Chim. Acta 18:267–273, 1967.
Stradins, P., R. Lacis, I. Ozolanta, B. Purina, V. Ose, L. Feldmane, and V. Kasyanov. Comparison of biomechanical and structural properties between human aortic and pulmonary valve. Eur. J. Cardiothorac. Surg. 26:634–639, 2004.
Syedain, Z. H., A. R. Bradee, S. Kren, D. A. Taylor, and R. T. Tranquillo. Decellularized tissue-engineered heart valve leaflets with recellularization potential. Tissue Eng. A 19:759–769, 2013.
Syedain, Z., M. T. Lahti, S. Johnson, P. Robinson, G. R. Ruth, R. Bianco, and R. Tranquillo. Implantation of a tissue engineered heart valve from human fibroblasts exhibiting short term function in the sheep pulmonary artery. Cardiovasc. Eng. Technol. 2:101–112, 2011.
Syedain, Z. H., L. A. Meier, J. W. Bjork, A. Lee, and R. T. Tranquillo. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials 32:714–722, 2011.
Syedain, Z. H., L. Meier, M. Lahti, S. Johnson, and R. T. Tranquillo. Implantation of completely biological, aligned engineered arteries pre-made from allogeneic fibroblasts in a sheep model. 2013 (submitted).
Syedain, Z. H., and R. T. Tranquillo. Controlled cyclic stretch bioreactor for tissue-engineered heart valves. Biomaterials 30:4078–4084, 2009.
Syedain, Z. H., and R. T. Tranquillo. TGF-beta1 diminishes collagen production during long-term cyclic stretching of engineered connective tissue: implication of decreased ERK signaling. J. Biomech. 44:848–855, 2011.
Syedain, Z. H., J. S. Weinberg, and R. T. Tranquillo. Cyclic distension of fibrin-based tissue constructs: evidence of adaptation during growth of engineered connective tissue. Proc. Natl. Acad. Sci. U. S. A. 105:6537–6542, 2008.
Tower, T. T., M. R. Neidert, and R. T. Tranquillo. Fiber alignment imaging during mechanical testing of soft tissues. Ann. Biomed. Eng. 30:1221–1233, 2002.
Weber, B., J. Scherman, M. Y. Emmert, J. Gruenenfelder, R. Verbeek, M. Bracher, M. Black, J. Kortsmit, T. Franz, R. Schoenauer, L. Baumgartner, C. Brokopp, I. Agarkova, P. Wolint, G. Zund, V. Falk, P. Zilla, and S. P. Hoerstrup. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates. Eur. Heart J. 32:2830–2840, 2011.
Williams, C., S. L. Johnson, P. S. Robinson, and R. T. Tranquillo. Cell sourcing and culture conditions for fibrin-based valve constructs. Tissue Eng. 12:1489–1502, 2006.
Acknowledgments
Authors will like to thank Naomi Ferguson, and Jillian Schmidt for technical assistance and Dave Hultman Design for machining the custom pulse duplicator system, bioreactor manifold and valve frames. The funding for the work was provided by NIH R01 HL107572 (to RTT).
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Jane Grande-Allen oversaw the review of this article.
Zeeshan H. Syedain and Lee A. Meier are the co-first authors.
Rights and permissions
About this article
Cite this article
Syedain, Z.H., Meier, L.A., Reimer, J.M. et al. Tubular Heart Valves from Decellularized Engineered Tissue. Ann Biomed Eng 41, 2645–2654 (2013). https://doi.org/10.1007/s10439-013-0872-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-013-0872-9